Sign in

CIK 0001708527

  • Non-accelerated filer
  • Smaller reporting company

ELUTIA INC.

Sign in to watch
Ticker
ELUT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474790334
Phone
+1 240-247-1143
Business address
12510 PROSPERITY DRIVE, SUITE 370, SILVER SPRING, MD, 20904
Former names
AZIYO BIOLOGICS, INC.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2022-03-08 LLOYD RONALD K. PRESIDENT AND CEO Option exercise +4,072 31,775
2022-03-08 LLOYD RONALD K. PRESIDENT AND CEO Grant or award · Stock Option (Right to Buy) +138,770 138,770
2022-03-08 LLOYD RONALD K. PRESIDENT AND CEO Grant or award · Restricted Stock Units +37,788 37,788
2022-03-08 LLOYD RONALD K. PRESIDENT AND CEO Option exercise · Restricted Stock Units −4,072 12,216
2022-03-08 LLOYD RONALD K. PRESIDENT AND CEO Grant or award · Restricted Stock Units +39,894 39,894
2021-05-07 LLOYD RONALD K. PRESIDENT AND CEO Purchase +7,198 $11.65 $84K 21,784
2021-05-07 LLOYD RONALD K. PRESIDENT AND CEO Purchase +1,367 $12.28 $17K 23,151
2021-03-08 LLOYD RONALD K. PRESIDENT AND CEO Grant or award · STOCK OPTION (RIGHT TO BUY) +97,725 97,725
2021-03-08 LLOYD RONALD K. PRESIDENT AND CEO Grant or award · RESTRICTED STOCK UNITS +16,288 16,288
2020-10-13 LLOYD RONALD K. President and CEO Conversion +14,586 14,586
2020-10-13 LLOYD RONALD K. President and CEO Conversion · Series A Convertible Preferred Stock −111,788 0
2020-10-07 LLOYD RONALD K. President and CEO Grant or award · Stock Option (Right to Buy) +181,783 181,783
2020-10-07 LLOYD RONALD K. President and CEO Grant or award · Restricted Stock Units +100,425 100,425

Page 1 of 1 · 13 trades